Recombinant Human BCL6 Protein, His-tagged
Cat.No. : | BCL6-306H |
Product Overview : | Recombinant Human BCL6 Protein (Met1-Tyr408) with N-His tag was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
- Download
Description : | The protein encoded by this gene is a zinc finger transcription factor and contains an N-terminal POZ domain. This protein acts as a sequence-specific repressor of transcription, and has been shown to modulate the transcription of STAT-dependent IL-4 responses of B cells. This protein can interact with a variety of POZ-containing proteins that function as transcription corepressors. This gene is found to be frequently translocated and hypermutated in diffuse large-cell lymphoma (DLCL), and may be involved in the pathogenesis of DLCL. Alternatively spliced transcript variants encoding different protein isoforms have been found for this gene. |
Source : | E. coli |
Species : | Human |
Tag : | His |
Form : | Freeze-dried powder |
Molecular Mass : | Predicted Molecular Mass: 49.1 kDa Accurate Molecular Mass: 49 kDa |
Protein length : | Met1-Tyr408 |
Purity : | > 90% |
Applications : | Positive Control; Immunogen; SDS-PAGE; WB. |
Stability : | The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 centigrade for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition. |
Storage : | Avoid repeated freeze/thaw cycles. Store at 2-8 centigrade for one month. Aliquot and store at -80 centigrade for 12 months. |
Storage Buffer : | PBS, pH7.4, containing 0.01% SKL, 1 mM DTT, 5% Trehalose and Proclin300. |
Reconstitution : | Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL. Do not vortex. |
Gene Name : | BCL6 B-cell CLL/lymphoma 6 [ Homo sapiens (human) ] |
Official Symbol : | BCL6 |
Synonyms : | BCL6; B-cell CLL/lymphoma 6; zinc finger protein 51, ZNF51; B-cell lymphoma 6 protein; BCL5; BCL6A; LAZ3; ZBTB27; BCL-5; BCL-6; protein LAZ-3; zinc finger protein 51; B-cell lymphoma 5 protein; B-cell lymphoma 6 protein transcript; zinc finger transcription factor BCL6S; cys-his2 zinc finger transcription factor; zinc finger and BTB domain-containing protein 27; lymphoma-associated zinc finger gene on chromosome 3; ZNF51 |
Gene ID : | 604 |
mRNA Refseq : | NM_001130845 |
Protein Refseq : | NP_001124317 |
MIM : | 109565 |
UniProt ID : | P41182 |
Products Types
◆ Recombinant Protein | ||
BCL6-352R | Recombinant Rhesus Macaque BCL6 Protein, His (Fc)-Avi-tagged | +Inquiry |
BCL6-996M | Recombinant Mouse BCL6 Protein, His (Fc)-Avi-tagged | +Inquiry |
Bcl6-701M | Recombinant Mouse Bcl6 Protein, MYC/DDK-tagged | +Inquiry |
BCL6-158H | Recombinant Human BCL6 Protein, GST-tagged | +Inquiry |
BCL6-441H | Recombinant Human BCL6 Protein, His (Fc)-Avi-tagged | +Inquiry |
◆ Lysates | ||
BCL6-8479HCL | Recombinant Human BCL6 293 Cell Lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewIts stability and structural integrity make it an ideal candidate for studying protein structures at high resolution.
I am delighted to highly recommend the BCL6 Protein for researchers seeking excellent performance in Western blotting (WB) experiments and protein electron microscopy structure analysis
Its exceptional purity and integrity ensure clear and reliable bands, enabling accurate detection and quantification of target proteins.
Q&As (5)
Ask a questionChallenges include the need to develop specific and effective inhibitors of BCL6 function while minimizing off-target effects and ensuring tolerability in clinical settings.
Yes, genetic mutations and translocations involving the BCL6 gene have been linked to the development of certain lymphomas and other hematological malignancies.
BCL6 protein is crucial for the formation and maintenance of germinal centers, where it regulates the processes of somatic hypermutation and class-switch recombination in B cells.
Targeting BCL6 protein could potentially offer new therapeutic options by modulating immune responses and suppressing the aberrant production of autoantibodies in autoimmune diseases.
Yes, the assessment of BCL6 protein expression can provide valuable prognostic information, helping to predict patient outcomes and guide treatment strategies for lymphoma patients.
Ask a Question for All BCL6 Products
Required fields are marked with *
My Review for All BCL6 Products
Required fields are marked with *
Inquiry Basket